Search research articles
Contact Us
Filters
Showing results (171-180 of 1,010) with videos related to
Page
of 101
Sort By:
Circulation
|
June 22, 2016
The Future of Cardiovascular Therapeutics
Calum A MacRae, Dan M Roden, Joseph Loscalzo
Nature Communications
|
June 7, 2022
The 3D mutational constraint on amino acid sites in the human proteome
Bian Li, Dan M Roden, John A Capra
Heart Rhythm
|
May 1, 2018
Arrhythmia genetics: Not dark and lite, but 50 shades of gray
Dan M Roden, Andrew M Glazer, Brett Kroncke
Annual Review of Genomics and Human Genetics
|
May 6, 2016
Phenome-Wide Association Studies as a Tool to Advance Precision Medicine
Joshua C Denny, Lisa Bastarache, Dan M Roden
Journal of Clinical Pharmacology
|
July 1, 1984
Antiarrhythmic therapy: clinical pharmacology update
R L Woosley, I Cerskus, D M Roden
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
August 1, 1993
Increase in skeletal muscle blood flow but not in renal blood flow during euglycemic hyperinsulinemia in man
H Vierhapper, S Gasic, M Roden, et al.
Circulation Research
|
May 1, 1999
Calmodulin kinase inhibition prevents development of the arrhythmogenic transient inward current
Y Wu, D M Roden, M E Anderson
Annals of Biomedical Engineering
|
February 24, 2001
Delayed activation and retrograde propagation in cardiac muscle: implication of virtual electrode effects
J Wu, D M Roden, J P Wikswo
Circulation
|
March 15, 1995
Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects
T Yang, D J Snyders, D M Roden
Metabolism: Clinical and Experimental
|
March 1, 1992
Endothelin-1-stimulated glucose production in vitro in the isolated perfused rat liver
M Roden, H Vierhapper, K Liener, et al.
Page
of 101
Search research articles
Search
Showing results (171-180 of 1,010) with videos related to
Sort By:
Page
of 101
Circulation
|
June 22, 2016
The Future of Cardiovascular Therapeutics
Calum A MacRae, Dan M Roden, Joseph Loscalzo
Nature Communications
|
June 7, 2022
The 3D mutational constraint on amino acid sites in the human proteome
Bian Li, Dan M Roden, John A Capra
Heart Rhythm
|
May 1, 2018
Arrhythmia genetics: Not dark and lite, but 50 shades of gray
Dan M Roden, Andrew M Glazer, Brett Kroncke
Annual Review of Genomics and Human Genetics
|
May 6, 2016
Phenome-Wide Association Studies as a Tool to Advance Precision Medicine
Joshua C Denny, Lisa Bastarache, Dan M Roden
Journal of Clinical Pharmacology
|
July 1, 1984
Antiarrhythmic therapy: clinical pharmacology update
R L Woosley, I Cerskus, D M Roden
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
August 1, 1993
Increase in skeletal muscle blood flow but not in renal blood flow during euglycemic hyperinsulinemia in man
H Vierhapper, S Gasic, M Roden, et al.
Circulation Research
|
May 1, 1999
Calmodulin kinase inhibition prevents development of the arrhythmogenic transient inward current
Y Wu, D M Roden, M E Anderson
Annals of Biomedical Engineering
|
February 24, 2001
Delayed activation and retrograde propagation in cardiac muscle: implication of virtual electrode effects
J Wu, D M Roden, J P Wikswo
Circulation
|
March 15, 1995
Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects
T Yang, D J Snyders, D M Roden
Metabolism: Clinical and Experimental
|
March 1, 1992
Endothelin-1-stimulated glucose production in vitro in the isolated perfused rat liver
M Roden, H Vierhapper, K Liener, et al.
Page
of 101